The highly regulated process of adapting to cellular nutritional status depends on lysosomal mTORC1 (mechanistic Target of Rapamycin Complex 1), that integrates nutrients availability via the sensing of amino acids to promote growth and anabolism 1 . Nutrient restriction inhibits mTORC1 activity, which in turn induces autophagy, a crucial adaptive process that recycles internal nutrient stores to promote survival 2 . However, as successful amino acid recycling through autophagic degradation reactivates mTORC1 signaling over time 3,4 , it is unclear how autophagy can be maintained during prolonged starvation. Here, we show that one particular amino acid, cysteine, acts in a feedback loop to limit mTORC1 reactivation in vivo. We provide evidence that lysosomal export of cystine through the cystine transporter cystinosin fuels a metabolic pathway that suppresses mTORC1 signaling and maintains autophagy during starvation. This pathway involves reduction to cysteine, cysteine catabolism to acetyl-CoA and subsequent fueling of the TCA cycle. Accordingly, the starvation sensitivity phenotype of animals lacking cystinosin is rescued by dietary supplementation with cysteine and TCA cycle components as well as by reducing mTORC1 activity. We propose that cysteine mediates a communication between lysosomes and mitochondria to control mTORC1 signaling under prolonged starvation, highlighting how changes in nutrient availability divert the fate of an amino acid into a growth suppressive program to maintain the balance between nutrient supply and consumption.
Organisms constantly cope with variations in nutrient supply by adjusting metabolism, a process controlled by the major growth regulator mTORC1. Nutrient scarcity inhibits mTORC1 to limit growth and promote catabolic programs, including autophagy. Autophagy involves the sequestration of cytosolic material into autophagosomes that fuse with lysosomes for cargo degradation and recycling. Efficient lysosomal degradation generates new amino acids that in turn reactivate mTORC1 [3] [4] [5] [6] . However, how mTORC1 inhibition and activation is balanced over the course of starvation remains unclear.
To study this process in vivo, we used the Drosophila larval fat body, an organ analogous to the liver and adipose tissue in mammals with important functions during starvation 2, 7 . As in mammalian cells, prolonged starvation led to mTORC1 reactivation in fat bodies, which was dependent on autophagy induction (Fig. 1a, b and Extended Data Fig 1a) . To identify signals controlling mTORC1 activity upon fasting, we focused on amino acids and performed an unbiased approach to analyze growth of fasted larvae under single amino acid supplementation (Supplementary Methods). Unexpectedly, this screen revealed cysteine as a unique amino acid associated with growth suppressive properties (Supplementary Text 1, Fig. 1c and Extended Data Fig. 1b-e ). This process required mTORC1 inhibition as constitutive activation of mTORC1 in Gator1 mutants (nprl2 -/-) 8 partially restored growth under cysteine supplementation (Fig. 1d) . Consistently, cysteine treatment partially inhibited mTORC1 activity in fat bodies (Extended Data Fig. 1f ).
We reasoned that, as lysosomal efflux of nutrients promotes mTORC1 reactivation 3 , cysteine could limit this process. In physiological conditions, cellular cysteine can either be synthesized in the cytosol or transported as cystine from the extracellular space by the Xc -antiporter 9 and by cystinosin from the lysosome 10 ( Fig. 1e ). Thus, we analyzed whether cysteine recycling through cystinosin opposes mTORC1 reactivation upon fasting. Cystinosin is encoded by CTNS, a gene mutated in the lysosomal storage disorder cystinosis 11 . The Drosophila genome contains a single ortholog of CTNS (CG17119), hereafter referred to as dCTNS. Endogenous tagging of cystinosin in Drosophila confirmed its specific lysosomal localization in fat body cells, and dCTNS -/-larvae showed accumulation of cystine (Extended Data Fig. 2a-c) , consistent with a role for cystinosin in lysosomal cystine transport. In fed conditions, control and dCTNS -/-larvae showed similar cysteine levels, likely reflecting dietary intake as the main source of cysteine (Fig.1f) . However, upon fasting, cysteine levels dropped in dCTNS -/-larvae, and maintenance of cysteine levels required autophagy (Fig. 1f, g ). Thus, we conclude that cystinosin recycles cysteine from autophagic degradation upon fasting.
Next, we analyzed the role of cystinosin on mTORC1 reactivation during fasting. dCTNS knockdown in larval fat body (lpp-gal4) did not affect mTORC1 during the early phase of starvation. However, it slightly increased mTORC1 reactivation upon prolonged starvation (Fig. 1h) . Analysis of dCTNS -/-fat body clones showed that this effect was cell autonomous (Extended Data Fig. 2d ) and sufficient to compromise maintenance of autophagy (Extended Data Fig. 2e ). Conversely, dCTNS overexpression increased cysteine levels (Fig. 1i) , which caused downregulation of mTORC1 and induction of autophagy ( Fig. 1i and Extended Data Fig. 2e ). Similar to cysteine treatment, dCTNS overexpression caused a developmental delay in both fed and starved conditions (Extended data Fig. 2f ), in agreement with mTORC1 activity promoting growth during development. Finally, dCTNS loss of function led to starvation sensitivity in both larvae and adult animals (leading to a developmental delay in larvae, see Supplementary text 2), consistent with the importance of mTORC1 downregulation and autophagy induction for survival upon fasting 2 (Extended Data Fig. 2g-i ). This was dependent on cystine efflux as treatment with cysteamine (which exports cystine out of the lysosome independently of cystinosin 12 ) rescued the starvation sensitivity of dCTNS -/-animals (Extended Data Fig. 2k ). In addition, treatment with low concentration of cysteine (that did not affect development of control animals) and the mTORC1 inhibitor rapamycin, respectively, also restored resistance to starvation of dCTNS -/-animals ( Fig.  1j-l) , indicating that cystinosin controls mTORC1 through cytosolic cysteine. Altogether, we demonstrate that lysosomal-derived cysteine restricts mTORC1 reactivation to a threshold that maintains autophagy upon prolonged fasting.
Following reduction of cytosolic cystine to cysteine 13 , cysteine catabolism generates byproducts 14, 15 . To discriminate between the effect of cysteine and these byproducts on mTORC1 inhibition, we sought to genetically suppress cysteine degradation. In mammals, cysteine degradation in liver and adipose tissues is catalyzed by cysteine dioxygenase type 1 (CDO1), a nucleo-cytoplasmic enzyme that generates cysteine sulfinate (CSA), a precursor for pyruvate and taurine synthesis 14, 16, 17 (Fig. 2a) . The Drosophila genome contains a single ortholog of CDO1 encoded by CG5493 (referred to as dCDO) that is strongly expressed in the fat body (Extended Data Fig. 3a) . dCDO -/-larvae showed decreased levels of CSA and taurine, and dCDO knockdown in the fat body led to cysteine accumulation, particularly in larvae fed cysteine-enriched food, consistent with a role for dCDO in cysteine degradation ( Fig. 2b; Extended Data Fig. 3b) . Further, inhibition of mTORC1 by cysteine supplementation was suppressed in dCDO -/-animals ( Fig. 2c) , suggesting that cysteine requires degradation to CSA to control mTORC1. Accordingly, CSA supplementation had a similar effect than cysteine on growth and mTORC1 activity (Extended Data Fig. 3c, d ). In addition, downregulation of dCDO in the larval fat body suppressed the developmental delay and the inhibition of mTORC1 induced by dCTNS overexpression, whereas CSA treatment restored the inhibition of mTORC1 (Extended Data Fig. 2d , e; Extended Data Fig. 3e) . Consistently, dCDO knockdown in the fat body led to a stronger reactivation of mTORC1 under prolonged fasting ( Fig. 2f; Extended Data Fig. 3f, g ). Finally, aberrant mTORC1 reactivation following dCDO knockdown impaired fasting-induced autophagy (Fig. 2g) . In sum, our data show that lysosomal cystine efflux and subsequent cysteine degradation into CSA opposes mTORC1 reactivation to maintain autophagy upon prolonged fasting.
Since amino acids and amino acid catabolism are potent activators of mTORC1 18, 19 , our finding that cysteine degradation limits mTORC1 reactivation is unexpected and prompted further analysis of the respective downstream events. As CSA is used for the synthesis of pyruvate and taurine, we first tested their effects on growth. Treatment with pyruvate but not with taurine, resembled the effects of cysteine and CSA on growth (Extended Data Fig. 4a ), hinting at a role for the cysteine/pyruvate metabolic route in the control of mTORC1 reactivation. Consistently, supplementing food with pyruvate partially rescued starvation sensitivity of dCTNS -/-animals ( Fig. 3a) . In accordance with pyruvate function in fueling the TCA cycle, animals treated with excess cysteine showed increased levels of pyruvate and TCA cycle intermediates, particularly upon starvation (Fig.  3b, c) . Accordingly, in physiological conditions (without cysteine supplementation), the level of many TCA cycle intermediates measured either from whole larvae or the fat body acutely increased during starvation, eventually reaching a steady state comparable to the levels of fed animals (Extended Data Fig. 4b-d ). Essential amino acids were acutely depleted upon fasting, whereas the level of non-essential amino acids that requires TCA cycle activity was maintained. Importantly, maintenance of the level of TCA cycle intermediates required cysteine, as dCTNS -/-animals showed a pronounced depletion of pyruvate and TCA cycle intermediates upon prolonged fasting but not in fed conditions (Fig. 3d) . By contrast, overexpression of dCTNS in fed animals led to opposite results (Fig. 3d) . In sum, these data indicate that cysteine catabolism maintains TCA cycle activity upon fasting.
Pyruvate can contribute carbons to the TCA cycle through two metabolic routes. One serves an anaplerotic function to replenish oxaloacetate through the enzyme pyruvate carboxylase (PC), while the other contributes carbon in the form of acetyl-CoA through the pyruvate dehydrogenase complex (PDHc) (Fig. 3b) . [U-13 C3]cysteine labeling experiments in vivo revealed incorporation of cysteine carbons into CSA and acetylCoA in a dCDO-dependent manner in dissected fat bodies, indicating that cysteine/CSA provides substrate for PDHc (Extended Data Fig. 4e ). However, due to very low labeling in the TCA cycle (see details in Supplementary text 3, Extended Data Fig. 5 ), we could not rule out a role for minimal cysteine anaplerosis through PC. Thus, we further used genetics to discriminate between PC and PDHc pathways on the regulation of mTORC1 by cysteine. Knockdown of PC (pcb/CG1516) suppressed mTORC1 reactivation upon fasting, whereas knockdown of pyruvate dehydrogenase phosphatase (pdp), which leads to PDHc inhibition 20 , caused a stronger reactivation of mTORC1 (Fig. 4a, b) . This was supported by silencing pdha (the rate limiting enzyme of PDHc) in both entire fat bodies and in clones (Fig. 4c, Extended data Fig. 6a) . Accordingly, inhibition of mTORC1 by dCTNS overexpression or cysteine supplementation was suppressed by knockdown of pdp (Fig.  4d, Extended data Fig. 6b ). Finally, inhibition of PDHc impaired autophagy in larvae and triggered starvation intolerance in adult animals, similar to inhibition of dCTNS and dCDO (Fig. 4e, Extended data Fig. 6c ). Thus, lysosomal cystine efflux and subsequent degradation to pyruvate opposes mTORC1 signaling reactivation through PDHc-dependent entry of acetyl-CoA into the TCA cycle.
To analyze whether the levels of particular TCA cycle intermediates downstream acetyl-CoA was relevant in the regulation of mTORC1, we screened for their effect on growth. We focused on fumarate, because it was the only TCA cycle intermediate associated with growth retardation (Extended data Fig. 6d, e) . Fumarate treatment suppressed mTORC1 activity and rescued the effect of dCDO knockdown on mTORC1 in a dCTNS overexpression background (Extended data Fig. 6f, Fig. 4f ). Finally, fumarate treatment partially rescued starvation sensitivity of dCTNS -/-animals ( Fig. 4g) , suggesting that the level of TCA cycle intermediates act downstream cystinosin during inhibition of mTORC1 activity. Alternatively, or in parallel, acetyl-CoA from cysteine could directly increase fumarate production through stabilization of cofactors required maximal activity of the fumarate-producing succinate dehydrogenase complex (complex II), as recently described 21 .
In sum, we demonstrate that upon prolonged starvation, cysteine degradation to acetyl-CoA limits mTORC1 signaling reactivation through the TCA cycle to maintain autophagy (Fig. 4h) .
Maintaining cellular homeostasis upon nutrient shortage is an important challenge for all animals. On the one hand, downregulation of mTORC1 is necessary to limit translation, reduce growth rates and engage autophagy. On the other hand, minimal mTORC1 activity is required to promote lysosomes biogenesis, thus maintaining autophagic degradation necessary for survival 22 . Here, we identify another critical layer of regulation that prevents reactivation of mTORC1 above a threshold that would compromise autophagy and survival upon fasting. Thus, reactivation of mTORC1 upon fasting is not passively controlled by the extent of nutrient remobilization, but instead is actively regulated by a mitochondrial pathway that maintains autophagy during starvation. Interestingly, this pathway is initiated by autophagy itself, as autophagic protein degradation controls cystine availability that further limits mTORC1 signaling through the TCA cycle.
Whether particular TCA cycle metabolites such as fumarate directly mediate mTORC1 inhibition remains unclear. Alternatively, acetyl-CoA from cysteine could promote incorporation of anaplerotic inputs into the TCA cycle at the expense of their use for biosynthesis of mTORC1-activating metabolites. Another open question concerns the crosstalk with mTORC1-activating pathways involving the TCA cycle. Our data show, for example, that knockdown of PC that replenishes oxaloacetate suppresses mTORC1 reactivation during fasting, whereas mitochondrial acetyl-CoA metabolism derived from cysteine via PDHc limits mTORC1 reactivation to a certain threshold. By contrast, cytosolic acetyl-CoA derived from leucine metabolism has recently been described to promote S6K phosphorylation through acetylation of mTORC1 regulators 23 . This illustrates how the source and fate of acetyl-CoA dictates its differential roles for mTORC1 activity. Further studies will therefore be required to understand exactly how different inputs in the TCA cycle interact to adjust mTORC1 activity, and how cysteine catabolism affects this system. Figure 1 : Lysosomal cystine efflux limits mTORC1 reactivation to maintain autophagy upon prolonged fasting. a,b) Prolonged fasting leads to mTORC1 reactivation through autophagy. Phosphorylation levels of the direct mTORC1 target S6K in dissected fat bodies from larvae starved on PBS. c) Amino acid screen reveals cysteine as a growth suppressor. Time to pupariation for larvae fed a minimal diet supplemented with the indicated amino acids ad libitum. d) Constitutive mTORC1 activity partially suppresses the effect of cysteine on growth. Fed and fasted, control and Gator1 mutant (nprl2) larvae supplemented with 5 mM cysteine or vehicle ad libitum. e) Schematic of lysosomal cystine (CySS) efflux through cystinosin. f, g) Cystinosin and autophagy control cysteine levels. Cysteine levels measured from whole fed or starved larvae. Control is GFP RNAi (GFP-i). f) Controls are heterozygote animals (dCTNS +/-). h) Loss of cystinosin leads to higher mTORC1 reactivation upon prolonged starvation/fasting. P-S6K levels in fat bodies from larvae starved on PBS. i) dCTNS overexpression (lpp>dCTNS) increases cysteine levels and suppresses mTORC1 activity. Whole body cysteine levels and P-S6K levels in fat body from fed or starved larvae (controls are GFP-i). j-l) Cysteine and rapamycin treatments rescue starvation sensitivity of dCTNS -/-animals. Lifespan of adult flies on chemically defined media (j) and developmental time of larvae (k,l). Control is w 1118 (j) and dCTNS +/-(k,l). Fold change metabolite abundance measured by LC-MS/MS in larval fat bodies. c) Cysteine suppresses mTORC1 through dCDO. P-S6K levels in fat body from fed larvae supplemented with 1 mM cysteine for 4h. d) Cystinosin suppresses growth through dCDO. Developmental timing of larvae. e) Cystinosin inhibits mTORC1 through dCDO. P-S6K levels in fat body. Control is GFP-i. f) Loss of dCDO leads to higher reactivation of mTORC1 upon prolonged fasting. P-S6K levels in fat body from larvae starved on PBS or fasted. g) dCDO is necessary to maintain autophagy. Flip-out clones (GFP, outlined) in larvae fasted for 6 hours. Scale bar 20 μm. Knockdown of pcb suppresses mTORC1 reactivation upon prolonged fasting. P-S6K levels in fat body from larvae starved on PBS. b) Loss of Pdp leads to higher reactivation of mTORC1 upon prolonged fasting. P-S6K levels in fat body from larvae starved on PBS. c) Loss of Pdha leads to higher reactivation of mTORC1 (evidenced by P-4EBP levels) upon prolonged fasting. Flip-out clones (GFP, outlined) in larvae fed or fasted 12 hours. Scale bar 20 μm. d) Cystinosin suppresses mTORC1 through Pdp. P-S6K levels in fat body from fed larvae. e) Loss of Pdha impairs the induction of autophagy upon starvation. Flip-out clones (GFP, outlined) in fasted larvae. Scale bar 20 μm. f) Fumarate acts downstream cystinosin and dCDO to inhibit mTORC1 signaling. P-S6K levels in fat bodies from larvae treated with vehicle or 5mM dimethyl-fumarate (DMF). g) Fumarate partially restores starvation resistance of dCTNS -/-animals. Adult Lifespan and larval developmental time. Control is w 1118 . h) Model: cysteine metabolism maintains autophagy upon prolonged fasting. 
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Methods
Fly stocks and maintenance
Developmental timing
Three-day-old crosses were used for 3-4 hour periods of egg collection on lab food. Newly hatched L1 larvae were collected 24 hours later for synchronized growth using the indicated diets at a density of 30 animals/vial. The time to develop was monitored by counting the number of animals that underwent pupariation, every two hours in fed conditions or once/twice a day in starved conditions. The time at which half the animals had undergone pupariation is reported, +/-SEM.
Life span experiments
To generate age-synchronized adult flies, larvae were raised on ad libitum (means food available at all times with the quantity and frequency of consumption being the free choice of the animal) lab food at low density, transferred to fresh food upon emerging as adults and mated 48h. Animal were anaesthetized with low levels of CO2 and males sorted at a density of ten per vial. Each condition contained 8-10 vials. Each experiment was repeated at least 3 times and the averages values of each experiment were used for statistical analysis. Flies were transferred to fresh vials three times per week at which point deaths were scored. After ten days, deaths were scored every day.
Metabolite profiling
For whole body metabolic profiling, 25-38 mid-second instar or 8-15 mid-third instar larvae per sample were collected, snap-frozen in liquid nitrogen and stored at -80°C in extraction buffer (4-6 biological replicates/experiment). For fat body metabolic profiling, fat bodies from 35-40 larvae 96h AEL old were dissected in 25 ul PBS, diluted in 300 ul cold extraction buffer and snap frozen. Tissues were homogenized in extraction buffer using 1 mm zirconium beads (Next Advance, ZROB10) in a Bullet Blender tissue homogenizer (Model BBX24, Next Advance). Metabolites were extracted using 80 % (v/v) aqueous methanol (x2 sequential extractions with 300-600 ul) and metabolites pelleted by vacuum centrifugation. Pellets were resuspended in 20 ul HPLC-grade water and metabolomics data were acquired using targeted liquid chromatography tandem mass spectrometry (LC-MS/MS). A 5500 QTRAP hybrid triple quadrupole mass spectrometer (AB/SCIEX) coupled to a Prominence UFLC high-performance LC (HPLC) system (Shimadzu) was used for steady-state analyses of the samples. Selected reaction monitoring (SRM) of 287 polar metabolites using positive/negative switching with hydrophilic interaction LC (HILIC) was performed. Peak areas from the total ion current for each metabolite SRM Q1/Q3 transition were integrated using MultiQuant version 2.1 software (AB/SCIEX). The resulting raw data from the MultiQuant software were normalized by sample weight or protein content measured from equivalent samples and analyzed using Prism informatic software. Alternatively, 75 hours AEL old dCTNS +/-(control) or dCTNS -/-larvae were transferred either to fresh standard food (fed) or on PBS-soaked (starvation, 8h) Whatman paper. Larvae were rinsed with water, 70% ethanol and PBS to remove food and bacteria. 10-15 mid-third instar larvae per sample were collected, snapfrozen in liquid nitrogen and stored at -80°C until extraction in 50% methanol, 30% ACN, and 20% water. The volume of extraction solution added was adjusted to larvae mass (40mg/ml), samples were vortexed for 5 min at 4°C, and then centrifuged at 16,000 g for 15 minutes at 4°C. Supernatants were collected and analyzed by LC-MS using a QExactive Plus Orbitrap mass spectrometer equipped with an Ion Max source and a HESI II probe and coupled to a Dionex UltiMate 3000 UPLC system (Thermo, USA). An SeQuant ZIC-pHilic column (Millipore) was used for liquid chromatography separation 24 . The aqueous mobile-phase solvent was 20 mM ammonium carbonate plus 0.1% ammonium hydroxide solution and the organic mobile phase was acetonitrile. The metabolites were separated over a linear gradient from 80% organic to 80% aqueous for 15 min and detected across a mass range of 75-1,000 m/z at a resolution of 35,000 (at 200 m/z) with electrospray ionization and polarity switching mode. Lock masses were used to insure mass accuracy below 5 ppm. The peak areas of different metabolites were determined using TraceFinder software (Thermo) using the exact mass of the singly charged ion and known retention time on the HPLC column. In total, the metabolic profiling experiment was performed three times with 3-7 biological replicates per genotype.
TCA cycle isotopomer method from [U-
13 C3]cysteine and [U-13 C6]glucose Fed and starved early second instar animals were supplemented with the indicated concentrations of [U-13 C3]cysteine, [U-13 C6]glucose or vehicle in the food during the indicated time. Sample were collected (5-6 biological replicates for labelled conditions, 4 biological replicates for unlabeled condition), and intracellular metabolites were extracted using 80% (v/v) aqueous methanol. Q1/Q3 SRM transitions for incorporation of 13C labeled metabolites were established for isotopomers for 65 polar metabolites and data were acquired by LC-MS/MS. Peak areas were generated using MultiQuant 2.1 software. The mean peak areas from unlabeled conditions were used for background determination and were subtracted from each corresponding 13C labelled dataset.
Immunostaining
Tissues from 68-85 hours AEL larvae were dissected in phosphate-buffered saline (PBS) 2% formaldehyde at room temperature, fixed 20-30 min in 4% formaldehyde, washed twice 10 min in PBS 0.3% Triton (PBST), blocked 30 min (PBST, 5% BSA, 2% FBS, 0.02% NaN3), incubated with primary antibodies in the blocking buffer overnight and washed 4 times for 15 min. Secondary antibodies diluted 1:200 or 1:500 in PBST w ere added for 1 hour and tissues washed 4 times before mounting in Vectashield/DAPI. Rabbit anti P-4EBP1 was from Cell Signaling Technologies (CST 236B4, #2855) and diluted 1:500, rabbit anti-tRFP was from Evrogen (#AB233) and used against mKate2 to stain cystinosin-mKate2. Samples were imaged using Zeiss LSM 780 and Leica TCS SP8 SMD confocal systems with a 40x water or 40x oil immersion objective and images were processed with Fiji software.
Western Blots
Tissues from 15-30 animals were dissected in CST lysis buffer (Cat#9803) containing 2x protease inhibitor (Roche, 04693159001) and 3x phosphatase inhibitor (Roche, 04906845001), and homogenized using 1 mm zirconium beads (Next Advance, ZROB10) in a Bullet Blender tissue homogenizer (Model BBX24, Next Advance). Protein content was measured to normalize samples, 2x Laemmli Sample Buffer (Biorad) was added and samples boiled 6 min @ 95°C. Lysates were resolved by electrophoresis (Mini-PROTEAN TGX Precast Gels, BioRad; or PAGEr EX Gels, Lonza; or home-made gels), proteins transferred onto PVDF membranes (Immobilon P, Millipore), blocked in Tris-buffered saline with or without 0.1% Tween-20 buffer containing 3 or 6% BSA, and probed with P-S6K antibody (1:1000, CST 9209). After P-S6K was revealed, membranes were stripped for 5-30 min (Restore PLUS Buffer, Thermo Scientific #46430), washed, blocked in PBS Tween-20 buffer containing 5% dry milk, and probed with S6K antibody (1:10000, a gift from Aurelio Teleman 25 ). For normalization blots were probed with GADPH antibody (1:5000, GeneTex GTX100118). Data show representative results from at least 2 or 3 biological replicates. Horseradish peroxidase (HRP) conjugated secondary IgG antibodies (1:10000) were used together with the SuperSignal West Dura Extended Duration Substrate (Thermo Scientific #34076) to detect the protein bands.
Generation of clones
For autophagy experiments, clones were generated by crossing yw,hs-Flp; mCherry-Atg8a; Act>CD2>GAL4, UAS-nlsGFP/TM6B with the indicted UAS lines. Progeny of the relevant genotype was reared at 25°C and spontaneous clones were generated in the fat body due to the leakiness of the hs-flp. For dCTNS -/-clones, autophagy was analyzed by crossing w;; neoFRT82B, dCTNS -/-to hsFlp; R4-Gal4, UAS-mCherry-Atg8a; FRT82B UAS-GFP/TM6b. For P-4E-BP1 experiments, clones were either generated by crossing hsFlp; act>CD2>Gal4, UAS nls GFP with the indicted UAS lines or, for dCTNS -/-clones, by crossing w;;neoFRT82B, dCTNS -/-to yw, hsFlp, Tub-Gal4>UAS-nlsGFP/FM6;;neoFRT82B, TubGal80/TM6,Tb,Hu. F1 embryos collected overnight were heat shocked 3 times for 30 min.
Statistics
Experiments are presented with the mean +/-SEM. P values and significance: ns , P≥0.05; *, P0.05; **, P0.01; ***, P0.005; ****, P0.0001. Life span experiments: N=1 means average of 8-10 vials per genotype and condition in 1 experiment. Fig. 1j (N5), Fig. 3a (N=4), Fig. 4j (N=3-4) : significance was determined by a two-tailed t-test (Mann-Whitney). Pupariation assay: Fig. 1k, Fig. 1l, Fig. 2d, Fig. 3a, Fig. 4j : significance was determined by one-way ANOVA followed by a Bonferroni multiple comparisons test. Cysteine measurements (Profoldin kit): Fig. 1f, g: significance was determined by a one-way ANOVA followed by a Bonferroni multiple comparisons test. Fig. 1i : significance was determined by a two-tailed t-test (Mann-Whitney). Western blots: Fig 1h, Fig. 1i, Fig. 2e, Fig. 4i : significance was determined by one-way ANOVA followed by a Bonferroni multiple comparisons test. Fig 1a: spline curve represent the trend over multiple experiments. Fig 1b, 4a , 4b: significance was determined by two-way ANOVA followed by a Sidak's multiple comparisons test . Fig 2c, 2f , 4d: significance was determined by one-way ANOVA followed by a Tukey's multiple comparisons test. Metabolomics: Fig 2b, 2c: significance was determined by one-way ANOVA followed by a Tukey's multiple comparisons test . Fig 3d: significance was determined by a two-tailed t-test (Mann-Whitney).
